AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2015
Sep 3, 2015
30016_dirs_2015-09-03_fe008df6-2384-4980-8981-7cf5eb4937ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-09-01
Reporting Person: Studer Jacqueline (CVP, Gen. Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-01 | Common Stock | M | 1130 | $0.00 | Acquired | 1212 | Direct |
| 2015-09-01 | Common Stock | F | 365 | $70.54 | Disposed | 847 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-01 | Restricted Stock Unit | $ | M | 1130 | Disposed | Common Stock (1130) | Direct |
Footnotes
F1: The number of securities reported includes 82 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 6/30/2015.
F2: Represents restricted stock units previously granted on 09/01/2014 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (09/01/2015) of the date of grant. The number of restricted stock units reported was adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015.